May 26, 2019 by NewsBot - No Comment
About one in five Canadian adolescents uses cannabis. Neuroscientists have been researching the effects of cannabis on the adolescent brain. Adolescence is associated with the maturation of cognitive functions, such as working memory, decision-making, …
May 25, 2019 by NewsBot - No Comment
New research finds that self-weighing and seeing a graphical representation of their weight changes can prompt people to lose or maintain their weight.
May 24, 2019 by NewsBot - No Comment
A new study found that infants at high risk for autism were less attuned to differences in speech patterns than low-risk infants. The findings suggest that interventions to improve language skills should begin during infancy for those at high risk for …
May 24, 2019 by NewsBot - No Comment
A study in rats identifies a key driver of anhedonia, the inability to experience pleasure. This finding may lead to new therapies not just for depression.
May 24, 2019 by NewsBot - No Comment
As indicated by a recently published study, short-term opioid use shifts a range of emotional responses to the positive direction. This may be one of the reasons behind the onset of opioid use disorder.
May 24, 2019 by NewsBot - No Comment
The mental health of children and young people with some long term physical conditions could benefit from cognitive behavioral therapy (CBT), according to a recent study. The systematic review used robust methods to bring together and make sense of the…
May 24, 2019 by NewsBot - No Comment
Virtual reality (VR) can identify early Alzheimer’s disease more accurately than ‘gold standard’ cognitive tests currently in use, new research suggests.
May 23, 2019 by NewsBot - No Comment
New research shows memories are pliable if you know which regions of the brain’s hippocampus to stimulate — a finding that could someday enable personalized treatment for people with PTSD, depression and anxiety.
May 23, 2019 by NewsBot - No Comment
Targeting a key gene before birth could someday help lead to a treatment for Down syndrome by reversing abnormal embryonic brain development and improving cognitive function after birth, according to a new study.
May 23, 2019 by NewsBot - No Comment
A clinical trial for intranasal esketamine found it effective and safe for severe depression, leading to an FDA approval. But is this the end of the road?
